OA10601A - Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclicring - Google Patents

Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclicring Download PDF

Info

Publication number
OA10601A
OA10601A OA60973A OA60973A OA10601A OA 10601 A OA10601 A OA 10601A OA 60973 A OA60973 A OA 60973A OA 60973 A OA60973 A OA 60973A OA 10601 A OA10601 A OA 10601A
Authority
OA
OAPI
Prior art keywords
methyl
piperidine
furo
carbonyl
indole
Prior art date
Application number
OA60973A
Other languages
English (en)
Inventor
Leroy B Townsend
Susan Mary Daluge
Original Assignee
Wellcome Foundation Ltd The Re
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/304,006 external-priority patent/US5534535A/en
Application filed by Wellcome Foundation Ltd The Re filed Critical Wellcome Foundation Ltd The Re
Publication of OA10601A publication Critical patent/OA10601A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA60973A 1994-09-09 1997-03-07 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclicring OA10601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/304,006 US5534535A (en) 1992-03-09 1994-09-09 Therapeutic nucleosides

Publications (1)

Publication Number Publication Date
OA10601A true OA10601A (en) 2002-09-03

Family

ID=23174626

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60973A OA10601A (en) 1994-09-09 1997-03-07 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclicring

Country Status (17)

Country Link
EP (1) EP0779885A1 (cs)
JP (1) JPH10505092A (cs)
CN (1) CN1164855A (cs)
AP (1) AP741A (cs)
AU (1) AU3692895A (cs)
BR (1) BR9508826A (cs)
CA (1) CA2199502A1 (cs)
CZ (1) CZ71297A3 (cs)
FI (1) FI970959A7 (cs)
HU (1) HUT77440A (cs)
IS (1) IS4436A (cs)
NO (1) NO971070L (cs)
NZ (1) NZ294095A (cs)
OA (1) OA10601A (cs)
PL (1) PL319440A1 (cs)
SK (1) SK29197A3 (cs)
WO (1) WO1996007646A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912356A (en) * 1995-09-11 1999-06-15 Glaxo Wellcome Inc. Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
CA2280761A1 (en) 1997-02-13 1998-08-20 Stanley Dawes Chamberlain Benzimidazole derivatives
NZ502882A (en) 1997-07-30 2002-02-01 Glaxo Group Ltd Lyxofuranosyl benzimidazoles as antiviral agents
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
NZ514403A (en) 1999-12-27 2002-10-25 Japan Tobacco Inc Fused-ring compounds and use thereof as drugs
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CN1834090B (zh) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 苯并咪唑类化合物、其制备方法以及用途
WO2009042013A1 (en) 2007-08-02 2009-04-02 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
FI970959A7 (fi) 1997-05-06
IS4436A (is) 1997-03-07
AU3692895A (en) 1996-03-27
CA2199502A1 (en) 1996-03-14
BR9508826A (pt) 1997-09-30
AP9700940A0 (en) 1997-04-30
JPH10505092A (ja) 1998-05-19
WO1996007646A1 (en) 1996-03-14
EP0779885A1 (en) 1997-06-25
NZ294095A (en) 1998-08-26
CN1164855A (zh) 1997-11-12
AP741A (en) 1999-04-26
CZ71297A3 (en) 1997-08-13
PL319440A1 (en) 1997-08-04
NO971070L (no) 1997-05-07
NO971070D0 (no) 1997-03-07
HUT77440A (hu) 1998-04-28
MX9701789A (es) 1997-10-31
SK29197A3 (en) 1997-10-08
FI970959A0 (fi) 1997-03-06

Similar Documents

Publication Publication Date Title
AU697361B2 (en) Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
AU736303B2 (en) New heterocyclylmethyl-substituted pyrazol derivates
EP1804794B1 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease
EP1572113B1 (en) Calcium receptor modulating compound and use thereof
AU2009225343B2 (en) P38 inhibitors and methods of use thereof
EP1979355B1 (en) Spiro imidazole derivatives as ppar modulators
CA2693126A1 (en) Novel dicarboxylic acid derivatives as s1p1 receptor agonists
JPH04506222A (ja) Ｎ−置換複素環誘導体およびその製法
CZ358598A3 (cs) Karbolinové deriváty
EP0640085A1 (en) Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
JP2009543838A (ja) インドール化合物
OA10601A (en) Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclicring
TW200914457A (en) Pyrimidodiazepinone derivative
AU2009201867A1 (en) Compounds and compositions as LXR modulators
JP2009538865A (ja) ２−フェニル−５−アミノ−１，３，４−オキサジアゾールおよびニコチン性アセチルコチン受容体リガンドとしてのその使用
JPS6216949B2 (cs)
WO2014000629A1 (zh) 六氢并环戊二烯衍生物、其制备方法及其在医药上的应用
WO1993021182A1 (en) Heteroaromatic 5-hydroxytryptamine receptor agonists
AU2013339607A1 (en) 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel
JP2001525398A (ja) 選択的β３アドレナリン作動性アゴニスト
US7781460B2 (en) Substituted indazoles as inhibitors of phosphodiesterase type-IV
PT90097B (pt) Processo para a preparacao de novas 5,7-dihidro-pirrolo{3,2-f}benzoxazol-6-onas substituidas por substituintes heterociclicos, e de composicoes farmaceuticas que as contem
JP7637756B2 (ja) ｃＧＡＳ阻害剤
JP2002536436A (ja) スピロ環ケトン類およびそれのタキキニン拮抗薬としての使用
AU2005240816A1 (en) 6-substituted pyridoindolone derivatives production and therapeutic use thereof